Alten S.A [ATE] vs Capgemini SE [CAP] Detailed Stock Comparison
Alten S.A
Euronext
Loading...
Capgemini SE
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Alten S.A wins in 9 metrics, Capgemini SE wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Alten S.A | Capgemini SE | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.06 | 13.95 | Alten S.A |
| Price-to-Book Ratio | 1.09 | 1.92 | Alten S.A |
| Debt-to-Equity Ratio | 16.78 | 55.23 | Alten S.A |
| PEG Ratio | 9.46 | 10.26 | Alten S.A |
| EV/EBITDA | 6.52 | 8.64 | Alten S.A |
| Profit Margin (TTM) | 4.50% | 7.07% | Capgemini SE |
| Operating Margin (TTM) | 9.26% | 10.31% | Capgemini SE |
| EBITDA Margin (TTM) | 9.26% | 10.31% | Capgemini SE |
| Return on Equity | 8.78% | 14.32% | Capgemini SE |
| Return on Assets (TTM) | 6.29% | 6.24% | Alten S.A |
| Free Cash Flow (TTM) | $412.79M | $2.21B | Capgemini SE |
| Dividend Yield | 3.89% | N/A | N/A |
| 1-Year Return | -26.72% | -28.74% | Alten S.A |
| Price-to-Sales Ratio (TTM) | 0.59 | 0.97 | Alten S.A |
| Enterprise Value | $2.44B | $24.63B | Capgemini SE |
| EV/Revenue Ratio | 0.59 | 1.12 | Alten S.A |
| Revenue per Share (TTM) | $119 | $130 | Capgemini SE |
| Earnings per Share (Diluted) | $5.32 | $8.87 | Capgemini SE |
| Beta (Stock Volatility) | 1.34 | 0.96 | Capgemini SE |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Alten S.A vs Capgemini SE Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Alten S.A | 2.09% | 2.02% | -9.53% | -3.74% | -18.91% | -10.22% |
| Capgemini SE | 1.45% | 0.92% | -12.20% | -13.11% | -28.94% | -19.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Alten S.A | -26.72% | -47.59% | 3.97% | 58.70% | 224.39% | 224.39% |
| Capgemini SE | -28.74% | -33.21% | 12.80% | 46.25% | 342.25% | 342.25% |
Performance & Financial Health Analysis: Alten S.A vs Capgemini SE
| Metric | ATE | CAP |
|---|---|---|
| Market Information | ||
| Market Cap | €2.45B | €21.51B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 48,461 | 540,100 |
| 90 Day Avg. Volume | 44,803 | 474,675 |
| Last Close | €70.75 | €125.60 |
| 52 Week Range | €67.40 - €104.80 | €110.00 - €199.90 |
| % from 52W High | -32.49% | -37.17% |
| All-Time High | €163.30 (Jan 03, 2022) | €227.40 (Mar 04, 2024) |
| % from All-Time High | -56.67% | -44.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.00% |
| Quarterly Earnings Growth | -0.44% | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.07% |
| Operating Margin (TTM) | 0.09% | 0.10% |
| Return on Equity (TTM) | 0.09% | 0.14% |
| Debt to Equity (MRQ) | 16.78 | 55.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €63.50 | €64.56 |
| Cash per Share (MRQ) | €8.28 | €12.42 |
| Operating Cash Flow (TTM) | €430.40M | €2.44B |
| Levered Free Cash Flow (TTM) | €351.30M | €2.33B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.89% | N/A |
| Last 12-Month Dividend | €2.80 | N/A |
Valuation & Enterprise Metrics Analysis: Alten S.A vs Capgemini SE
| Metric | ATE | CAP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.06 | 13.95 |
| Forward P/E | 9.46 | 10.26 |
| PEG Ratio | 9.46 | 10.26 |
| Price to Sales (TTM) | 0.59 | 0.97 |
| Price to Book (MRQ) | 1.09 | 1.92 |
| Market Capitalization | ||
| Market Capitalization | €2.45B | €21.51B |
| Enterprise Value | €2.44B | €24.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.59 | 1.12 |
| Enterprise to EBITDA | 6.52 | 8.64 |
| Risk & Other Metrics | ||
| Beta | 1.34 | 0.96 |
| Book Value per Share (MRQ) | €63.50 | €64.56 |
Financial Statements Comparison: Alten S.A vs Capgemini SE
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATE | CAP |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATE | CAP |
|---|---|---|
| Cash & Equivalents | €302.09M | €2.79B |
| Total Current Assets | €1.84B | €9.31B |
| Total Current Liabilities | €1.11B | €7.71B |
| Long-Term Debt | €182.51M | €4.95B |
| Total Shareholders Equity | €2.13B | €11.80B |
| Retained Earnings | €118.20M | €7.21B |
| Property, Plant & Equipment | €57.45M | €2.07B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATE | CAP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ATE | CAP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 48,461 | 540,100 |
| Average Daily Volume (90 Day) | 44,803 | 474,675 |
| Shares Outstanding | 34.80M | 169.95M |
| Float Shares | 29.62M | 169.62M |
| % Held by Insiders | 0.17% | 0.09% |
| % Held by Institutions | 0.52% | 0.71% |
Dividend Analysis & Yield Comparison: Alten S.A vs Capgemini SE
| Metric | ATE | CAP |
|---|---|---|
| Last 12-Month Dividend | €2.80 | N/A |
| Last 12-Month Dividend Yield | 3.89% | N/A |
| 3-Year Avg Annual Dividend | €1.87 | N/A |
| 3-Year Avg Dividend Yield | 1.42% | N/A |
| 3-Year Total Dividends | €5.60 | N/A |
| Ex-Dividend Date | Jun 16, 2025 | N/A |